http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021162478-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0e9bca1120ab9d2f65b138f53e3eda4d |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-352 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-15 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-15 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-352 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
filingDate | 2021-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7006342a05c96751ee6d270995e85296 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_79a0a61aa01a185eb08418f691dc5e6a |
publicationDate | 2021-08-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | WO-2021162478-A1 |
titleOfInvention | Pharmaceutical composition for preventing or treating cancer, comprising genipin and elesclomol |
abstract | The present invention relates to a pharmaceutical composition comprising genipin and elesclomol, and, more particularly, to a pharmaceutical composition for preventing or treating cancer, comprising genipin and elesclomol. The pharmaceutical composition according to the present invention comprises genipin and elesclomol and can inhibit the growth of various cancer cells such as that in colorectal cancer, lung cancer, and breast cancer, and thus can be effectively used for a use of preventing or treating cancer. |
priorityDate | 2020-02-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 35.